BlueCrest Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,750
| Closed | -$58K | – | 702 |
|
|
2019
Q3 | $58K | Buy |
+26,750
| New | +$58K | ﹤0.01% | 535 |
|
|
2018
Q4 | – | Sell |
-191,241
| Closed | -$503K | – | 1726 |
|
|
2018
Q3 | $503K | Buy |
+191,241
| New | +$503K | 0.01% | 733 |
|
|
2018
Q2 | – | Sell |
-30,277
| Closed | -$89K | – | 2054 |
|
|
2018
Q1 | $89K | Buy |
+30,277
| New | +$89K | ﹤0.01% | 1358 |
|
|
2017
Q4 | – | Sell |
-25,453
| Closed | -$86K | – | 1220 |
|
|
2017
Q3 | $86K | Buy |
25,453
+14,391
| +130% | +$48.6K | ﹤0.01% | 776 |
|
|
2017
Q2 | $27K | Buy |
+11,062
| New | +$27K | ﹤0.01% | 855 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1301 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1072 |
|